Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-500
Closed -$176K 13
2026
Q1
$176K Buy
+500
New +$178K 0.01% 135
2025
Q4
Sell
-700
Closed -$198K 128
2025
Q3
$198K Buy
+700
New +$203K 0.02% 83
2022
Q4
Sell
-4,100
Closed -$925K 203
2022
Q3
$925K Sell
4,100
-5,300
-56% -$1.28M 0.08% 199
2022
Q2
$2.29M Sell
9,400
-10,100
-52% -$2.48M 0.17% 85
2022
Q1
$4.72M Buy
+19,500
New +$4.48M 0.18% 117
2021
Q4
Sell
-6,300
Closed -$1.34M 38
2021
Q3
$1.34M Buy
6,300
+3,000
+91% +$690K 0.09% 177
2021
Q2
$804K Buy
3,300
+2,300
+230% +$566K 0.08% 131
2021
Q1
$250K Buy
1,000
+800
+400% +$191K 0.02% 110
2020
Q4
$46K Buy
+200
New +$46.1K ﹤0.01% 128

Other funds holding AMGN

QVR's AMGN Position: Q2 2026 in Review

QVR sold out of Amgen (AMGN) in Q2 2026, closing a stake of 89 shares — an estimated $31.3K sold.

QVR first reported a position in AMGN in Q4 2020 and held it in 6 quarters. The position peaked at $439K in Q3 2022. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • QVR reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • QVR sold 89 Amgen shares in Q2 2026, an estimated $31.3K.
  • QVR first reported a position in Amgen in Q4 2020 and held it in 6 quarters.
  • QVR's Amgen position peaked at $439K in Q3 2022.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on QVR's 13F filing for Q2 2026.